STAAR Surgical Company
$25.53
▲
4.55%
2026-04-21 09:37:00
www.staar.com
NGM: STAA
Explore STAAR Surgical Company stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.27 B
Current Price
$25.53
52W High / Low
$30.81 / $15.59
Stock P/E
—
Book Value
$6.97
Dividend Yield
—
ROCE
-11.99%
ROE
-21.7%
Face Value
—
EPS
$-1.62
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
921
Beta
1.04
Debt / Equity
11.14
Current Ratio
4.55
Quick Ratio
3.74
Forward P/E
31.63
Price / Sales
5.47
Enterprise Value
$1.16 B
EV / EBITDA
-31
EV / Revenue
4.84
Rating
None
Target Price
$20.56
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Alcon Inc. | $77.24 | — | $30.37 B | 0.45% | 4.77% | 4.5% | $81.92 / $56.44 | $45.2 |
| 2. | Harvard Bioscience, Inc. | $6.99 | — | $30.92 M | — | 0.17% | -1.47% | $9.46 / $2.81 | $3.07 |
| 3. | Cuprina Holdings (Cayman) Limited | $0.33 | — | $2.47 M | — | 34.48% | -1.39% | $9.5 / $0.28 | $0.28 |
| 4. | Precision Optics Corporation, Inc. | $4.44 | — | $47.43 M | — | -40.7% | -73.56% | $6.04 / $3.55 | $1.21 |
| 5. | AptarGroup, Inc. | $125.33 | 21.29 | $8.05 B | 1.47% | 12.5% | 15.1% | $164.28 / $103.23 | $41.56 |
| 6. | Lucyd, Inc | $1.07 | — | $6.68 M | — | -93.41% | -83.6% | $4.97 / $0.95 | $1.65 |
| 7. | Baxter International Inc. | $18.8 | — | $9.79 B | 0.21% | 1.04% | -13.71% | $32.68 / $15.73 | $11.92 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 57.8 M | 94.73 M | 44.32 M | 42.59 M | 48.95 M | — |
| Operating Profit | -10.94 M | 24.44 M | -24.72 M | -34.74 M | -27.91 M | — |
| Net Profit | -18.31 M | 8.88 M | -16.81 M | -54.21 M | -34.23 M | — |
| EPS in Rs | -0.37 | 0.18 | -0.34 | -1.09 | -0.69 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 239.44 M | 313.9 M | 322.42 M | 284.39 M |
| Operating Profit | -45.95 M | -12.61 M | 28.1 M | 43.8 M |
| Net Profit | -80.45 M | -20.21 M | 21.35 M | 39.66 M |
| EPS in Rs | -1.62 | -0.41 | 0.43 | 0.8 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 451.68 M | 509.52 M | 488.69 M | 418.82 M |
| Total Liabilities | 107.49 M | 112.19 M | 102.74 M | 82.71 M |
| Equity | 344.18 M | 397.33 M | 385.95 M | 336.11 M |
| Current Assets | 311.55 M | 367.94 M | 365.27 M | 311.72 M |
| Current Liabilities | 68.5 M | 70.31 M | 65.04 M | 51.72 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -34.23 M | 15.72 M | 14.59 M | 35.72 M |
| Investing CF | 46.34 M | -59.22 M | 74.35 M | -156.38 M |
| Financing CF | -4.55 M | 5.72 M | 7.42 M | 8.3 M |
| Free CF | -40.05 M | -7.67 M | -3.59 M | 17.61 M |
| Capex | -5.82 M | -23.39 M | -18.19 M | -18.11 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -2.64% | 13.37% | — | — |
| Earnings Growth % | -194.66% | -46.18% | — | — |
| Profit Margin % | -6.44% | 6.62% | 13.95% | — |
| Operating Margin % | -4.02% | 8.71% | 15.4% | — |
| Gross Margin % | 76.32% | 78.36% | 78.55% | — |
| EBITDA Margin % | -1.82% | 10.3% | 16.99% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.